Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Apr;24(2):145-9.
doi: 10.4103/0970-1591.40605.

Antibiotic prophylaxis in pediatric urology

Antibiotic prophylaxis in pediatric urology

Seung-Hun Song et al. Indian J Urol. 2008 Apr.

Abstract

Urinary tract infection (UTI) is a common problem in infants and children. Children at risk for UTI such as vesicoureteric reflux (VUR) commonly receive prophylactic antibiotics to prevent renal scarring, which may lead to complications such as hypertension or end-stage renal disease. Recurrent UTI, with or without VUR, is the most common reason for long-term antibiotic prophylaxis in infants and children. However, the efficacy and importance of long-term antibiotic prophylaxis have not been assessed in well-controlled, prospective studies. Nitrofurantoin, trimethoprim/sulfamethoxazole have been used as prophylactic antibiotics for the prevention of UTI in children. Such medications are mostly safe in children for the long-term prophylactic therapy. Serious side effects are extremely rare and most are reversible with discontinuation of therapy. Although it is difficult to perform prospective studies in children and many factors are involved in the clinical course and prognosis of these patients, further studies are needed to evaluate the actual benefits of prophylactic antibiotics. Meanwhile, in infants and children with risk factors, long-term antibiotic prophylaxis should be considered, at least until there is evidence that these patients are not endangered by avoiding it.

Keywords: Antibiotic prophylaxis; child; urinary tract infections.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

Cited by

References

    1. Smellie JM, Katz G, Grüneberg RN. Controlled trial of prophylactic treatment in childhood urinary-tract infection. Lancet. 1978;2:175–8. - PubMed
    1. Lohr JA, Nunley DH, Howards SS, Ford RF. Prevention of recurrent urinary tract infections in girls. Pediatrics. 1977;59:562–5. - PubMed
    1. Smellie JM, Grüneberg RN, Normand IC, Bantock HM. Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection. Rev Infect Dis. 1982;4:461–6. - PubMed
    1. Smith J, Finn A. Antimicrobial prophylaxis. Arch Dis Child. 1999;80:388–92. - PMC - PubMed
    1. Winberg J, Bollgren I, Källenius G, Möllby R, Svenson SB. Clinical pyelonephritis and focal renal scarring. A selected review of pathogenesis, prevention and prognosis. Pediatr Clin North Am. 1982;29:801–14. - PubMed